Luscii + EXI: The New Partnership that Brings Health-Enhancing Exercise to Virtual Hospital Wards

Luscii Digital health platform Luscii, market leader in the growing space of virtual hospital wards, has announced a new partnership with digital therapeutic EXI that will allow it to integrate physical activity into its care pathways for the first time.

With over 15 years' experience across 11 markets, and as a partner of NHS England, Luscii provides over 100 different care pathways. These enable patients with a broad range of health conditions - from pregnancy and menopause to cardiac rehab, diabetes and several types of cancer - to be monitored remotely, avoiding unnecessary check-ups and hospital admissions and freeing up clinicians to allocate in-person time to those who need it most.

To ensure best-in-class support across all 100+ pathways, Luscii works with a wide range of trusted partners that each bring their expertise to be integrated into a specific pathway.

EXI - whose Software as a Medical Device (SaMD) platform is proven for 23 long-term health conditions and co-morbidities - will be the partner to integrate across multiple care pathways.

A Class 1 medical device, EXI draws on the latest clinical evidence for behavioural science and exercise to prescribe personalised, intensity-based physical activity that’s safe and achievable for those with long-term health conditions and co-morbidities. It then engages, guides and motivates each patient through a progressive prescription, offering a choice of suitable activities, tracking progress and providing behaviour change support - including rewards for achieving personal goals - to engage patients in their prescription, drive adherence and encourage sustained physical activity.

Adherence, activity and health data is also sent directly to the clinician, in real time, through a secure practitioner portal.

A wearable-first strategy is in place for EXI's partnership with Luscii, ensuring accuracy and breadth of health and activity data, as well as empowering patients to confidently complete prescriptions in the safe heart rate zone.

Initially launching into Luscii's cardiology and COPD pathways in the UK and Ireland, it is envisioned that EXI will, in time, be integrated into every pathway across all markets - all through the Luscii platform for one seamless experience.

Ruben de Neef, Head of Implementations and Partnerships at Luscii, said: "We see collaboration as the key to market-leading healthcare provision, and EXI's innovative approach to exercise prescription is a perfect fit for Luscii’s platform. We are excited to bring this new level of personalised care to patients together.”

EXI CEO Grace McNamara said: "Remote patient monitoring through virtual wards is proven to be one of the most efficient, cost-effective ways of managing people through multiple care pathways. This is a huge growth area, with the UK government now talking about virtually caring for 500,000 people every year. Similar conversations are taking place in the US. No matter what the condition-specific care pathway, incorporating personalised exercise is best practice.

"Within this field, Luscii is a world leader, deployed in over 10 NHS regions in the UK as well as 70 per cent of hospitals in its native Netherlands. It is also a trusted partner to Apple, Omron and PharmAccess.

"We're hugely excited by this partnership and the opportunity it presents to make a real difference to clinicians and to patients. Together, we are ready to enhance health outcomes at scale by seamlessly and intelligently bringing exercise into every patient’s health journey."

About Luscii

Luscii is the world’s most trusted digital health platform, providing all the necessary features for care at home in one easy-to-use app. Its goal is to revolutionise healthcare with the aid of technology, enabling virtual wards and preventing unnecessary hospital visits and admissions. With Luscii's digital healthcare concept and apps for iOS, Android and web, doctors and nurses can guide their patients remotely and directly from their electronic patient record. Over 100 care pathways are available in the Luscii Library, making it possible to support patients and improve care for every clinical pathway. Today, Luscii is active in 11 countries and is partner of NHS England. Luscii is an Apple Mobility Partner and has a global, strategic partnership with OMRON Healthcare.

www.luscii.com

About EXI

EXI is Exercise Intelligence - a Software as a Medical Device (SaMD), part of the emerging field of digital therapeutics, that supports professionals to prescribe and refer patients to exercise appropriately, and people with long-term health conditions to safely increase their physical activity. It's designed for up to 23 co-morbid physical and mental health conditions, including prevalent and serious non-communicable diseases (NCDs) such as obesity, cardiovascular disease, diabetes, hypertension, stroke, asthma, COPD, depression, anxiety and stress. Fully regulated and bringing together behaviour change science with the latest clinical evidence and physical activity guidelines, it delivers safe, scalable, measurable health interventions that are medically proven, achievable for the end user, and quick and simple to prescribe and monitor. It also harnesses behaviour change support and rewards to engage patients in their prescription, drive adherence and support sustained physical activity. A smartphone app supports end users while a secure data portal allows the professional to monitor outcomes and adherence.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...